Impact of radiation oncology practice on pain: A cross-sectional survey

Pignon, T.; Fernandez, Lucette; Ayasso, Sylvie; Durand, Marie-Agnés; Badinand, Delphine; Cowen, D.

doi:10.1016/j.ijrobp.2004.04.040

Cited by 42 publications

(33 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The prevalence of pain in patients during anticancer treatment (59%) was not significantly different from that in patients with advanced/ metastatic disease (64%). It is likely that there was considerable overlap in the condition of the patients in these two groups, because only two studies [6,61] on anticancer treatment patients included patients on curative/radical treatment alone. The other studies included more patients who were on palliative treatment than on curative treatment, so patients with and without metastases were combined.…”

Section: Discussionmentioning

confidence: 99%

“…Early reports on the prevalence of pain in cancer patients draw attention to high figures that ranged from 52% to 77% [1][2][3][4][5]. More recent studies on the prevalence of pain in patients with cancer showed figures that ranged from 24% to 60% in patients on active anticancer treatment [6][7][8][9] and 62%-86% in patients with advanced cancer [10][11][12][13][14][15], which illustrates that this problem has not been solved.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of pain in patients with cancer: a systematic review of the past 40 years

Everdingen

Rijke

Kessels³

et al. 2007

Annals of Oncology

1,638

859

View full text Add to dashboard Cite

Background: Despite the abundant literature on this topic, accurate prevalence estimates of pain in cancer patients are not available. We investigated the prevalence of pain in cancer patients according to the different disease stages and types of cancer.Patients and methods: A systematic review of the literature was conducted. An instrument especially designed for judging prevalence studies on their methodological quality was used. Methodologically acceptable articles were used in the meta-analyses.Results: Fifty-two studies were used in the meta-analysis. Pooled prevalence rates of pain were calculated for four subgroups: (i) studies including patients after curative treatment, 33% [95% confidence interval (CI) 21% to 46%]; (ii) studies including patients under anticancer treatment: 59% (CI 44% to 73%); (iii) studies including patients characterised as advanced/metastatic/terminal disease, 64% (CI 58% to 69%) and (iii) studies including patients at all disease stages, 53% (CI 43% to 63%). Of the patients with pain more than one-third graded their pain as moderate or severe. Pooled prevalence of pain was >50% in all cancer types with the highest prevalence in head/neck cancer patients (70%; 95% CI 51% to 88%). Conclusion:Despite the clear World Health Organisation recommendations, cancer pain still is a major problem.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Prevalence of pain in patients with cancer: a systematic review of the past 40 years

Everdingen

Rijke

Kessels³

et al. 2007

Annals of Oncology

1,638

859

View full text Add to dashboard Cite

show abstract

“…A total of 40% of individuals with early-or intermediate-stage cancer and 90% of individuals with advanced cancer have moderate-to-severe pain [1]. More recent studies on the prevalence of pain in patients with cancer showed figures that ranged from 24-60% in patients on active anticancer treatment [2][3][4] and 62-86% in patients with advanced cancer [5][6][7][8]. Up to 70% of patients with cancer-related pain do not receive adequate pain relief and this affects physical and psychological well-being, leading to a lower quality of life for the patient [9,10].…”

Section: Reviewmentioning

confidence: 99%

Quality of reporting and its correlates among randomized controlled trials on acupuncture for cancer pain: application of the CONSORT 2010 Statement and STRICTA

Lu¹,

Liao²,

Zeng³

et al. 2013

Expert Review of Anticancer Therapy

View full text Add to dashboard Cite

This study aims to analyze the quality of reporting and its correlates in randomized controlled trials (RCTs) on acupuncture for cancer pain. Quality of reporting for included papers was assessed against a subset of criteria adapted from the CONSORT 2010 statement and STRICTA. An overall quality score (OQS) and a combined key methodologic index score (MIS) was calculated for each trial. Factors associated with OQS and MIS were then identified. A total of 32 RCTs were included in the full text. The median OQS based on the CONSORT Statement and STRICTA was 4.0 and 0, respectively. The significant predictors for CONSORT OQS were year of publication and nationality of authors, for STRICTA it was nationality of authors and for MIS it was publication language. The quality of reporting in RCTs on acupuncture for cancer pain was poor. This indicates that RCTs on acupuncture for cancer pain need substantial improvement.

show abstract

“…Se estima que entre un 62 % a un 86 % de los pacientes con estados oncológicos avanzados presentan niveles elevados de dolor (3)(4)(5)(6)(7). Dentro de los procesos oncológicos, las metástasis son tan comunes como los tumores primarios y cuando se presentan lo hacen muy frecuentemente en sus formas osteolíticas con los conocidos perjuicios sobre los pacientes.…”

Section: Epidemiologíaunclassified

Sacroplastia

Clavo¹,

Valls²,

Font³

et al. 2014

Rev. Soc. Esp. Dolor

View full text Add to dashboard Cite

INTRODUCCIÓNLas fracturas sacras se pueden presentar como consecuencia de traumatismo directo o asociadas a fuerzas de estrés continuadas sobre un hueso debilitado, bien sea por estadios osteoporóticos avanzados o posteriores a la radioterapia (fracturas de estrés o fracturas por insuficiencia). La sacroplastia percutánea realizada bajo guía radiológica -fluoroscopia (arco en C) o con tomografía computerizada (TC)-es un procedimiento mínimamente invasivo que mejora el dolor y estabiliza la zona sacra (1).En las distintas series la mejoría del dolor puede ser cercana a porcentajes del 90 % en pacientes con fracturas y 60 al 70 % en patologías de origen neoplásico (2). Los mecanismos responsables del alivio del proceso doloroso obtenido tras la realización de esta técnica surgen por la posible acción combinada de la ablación termal neural tras la inyección, la neurolisis química y por la estabilización, fijación de la fractura sacra. EPIDEMIOLOGÍASe estima que entre un 62 % a un 86 % de los pacientes con estados oncológicos avanzados presentan niveles elevados de dolor (3-7). Dentro de los procesos oncológicos, las metástasis son tan comunes como los tumores primarios y cuando se presentan lo hacen muy frecuentemente en sus formas osteolíticas con los conocidos perjuicios sobre los pacientes. Se relacionan principalmente con tumores de próstata, mama, pulmón y presentan importante riesgo de asociar situaciones como aplastamiento vertebral y fracturas patológicas. Entre las consecuencias más frecuentes de las metástasis óseas se encuentran el dolor, las fracturas patológicas, la compresión radicular y la hipercalcemia.La región sacra, con un 21 %, es el tercer emplazamiento más frecuente de las metástasis, tras las vértebras dorsales (32 %) y la articulación del hombro (28 %). Las fracturas del sacro se presentan generalmente asociadas a cuadros de intenso dolor, discapacidad y complicaciones neuroló-gicas (8).Como parte del arsenal terapéutico intervencionista de las mismas, disponemos de la posibilidad de realizar fijaciones (9,11-13), sacrectomía parcial (10-12) o total y la sacroplastia percutánea. Esta última constituye una opción segura y efectiva como tratamiento mínimamente invasivo para el alivio del dolor y la estabilización de la zona sacra en régimen ambulatorio o con una mínima estancia hospitalaria (14,15). INDICACIONESDolor intratable en región sacra con evidencia radiológi-ca por medio de TC, RM o gammagráfía de fracturas a este nivel, lesiones captantes -secundarias a tumores primarios o bien secundarias a tumores en otras localizaciones (mieloma, cáncer de mama, próstata, pulmón…)-o derivadas de fracturas osteoporóticas.

show abstract

Impact of radiation oncology practice on pain: A cross-sectional survey

Cited by 42 publications

References 23 publications

Prevalence of pain in patients with cancer: a systematic review of the past 40 years

Prevalence of pain in patients with cancer: a systematic review of the past 40 years

Quality of reporting and its correlates among randomized controlled trials on acupuncture for cancer pain: application of the CONSORT 2010 Statement and STRICTA

Sacroplastia

Contact Info

Product

Resources

About